Interferon-regulatory factors determine macrophage phenotype polarization

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Günthner, Roman ^a   Anders, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERFERON REGULATORY FACTOR;

ANIMAL; CELL POLARITY; HUMAN; MACROPHAGE; PHENOTYPE; PHYSIOLOGY; REVIEW;

ANIMALS; CELL POLARITY; CYTOKINES; HUMANS; INTERFERON REGULATORY FACTORS; MACROPHAGES; PHENOTYPE;

EID: 84893834170     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/731023     Document Type: Review

References (95)

1. Geissmann F., Manz M. G., Jung S., Sieweke M. H., Merad M., Ley K., Development of monocytes, macrophages, and dendritic cells. Science 2010 327 5966 656 661 2-s2.0-76249095169 10.1126/science.1178331
2. Gordon S., Taylor P. R., Monocyte and macrophage heterogeneity. Nature Reviews Immunology 2005 5 12 953 964 2-s2.0-28544446111 10.1038/nri1733 (Pubitemid 41746764)
3. Gautier E. L., Shay T., Miller J., Gene-expression profiles and transcriptional regulatory pathways that underlie the identity and diversity of mouse tissue macrophages. Nature Immunology 2012 13 11 1118 1128
4. Wynn T. A., Chawla A., Pollard J. W., Macrophage biology in development, homeostasis and disease. Nature 2013 496 7446 445 455
5. Soos T. J., Sims T. N., Barisoni L., Lin K., Littman D. R., Dustin M. L., Nelson P. J., CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney International 2006 70 3 591 596 2-s2.0-33746482680 10.1038/sj.ki.5001567 (Pubitemid 44141588)
6. Jenkins S. J., Ruckerl D., Cook P. C., Jones L. H., Finkelman F. D., Van Rooijen N., MacDonald A. S., Allen J. E., Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 2011 332 6035 1284 1288 2-s2.0-79958715229 10.1126/science.1204351
7. Murray P. J., Wynn T. A., Protective and pathogenic functions of macrophage subsets. Nature Reviews Immunology 2011 11 11 723 737 2-s2.0-80355131976 10.1038/nri3073
8. Sica A., Mantovani A., Macrophage plasticity and polarization: in vivo veritas. The Journal of Clinical Investigation 2012 122 3 787 795 2-s2.0-84857883847 10.1172/JCI59643
9. Rock K. L., Latz E., Ontiveros F., Kono H., The sterile inflammatory response. Annual Review of Immunology 2010 28 321 342 2-s2.0-77952294609 10.1146/annurev-immunol-030409-101311
10. Swaminathan S., Griffin M. D., First responders: understanding monocyte-lineage traffic in the acutely injured kidney. Kidney International 2008 74 12 1509 1511 2-s2.0-57049125060 10.1038/ki.2008.555
11. Gordon S., Alternative activation of macrophages. Nature Reviews Immunology 2003 3 1 23 35 2-s2.0-0037265240 10.1038/nri978 (Pubitemid 37328697)
12. Anders H.-J., Ryu M., Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney International 2011 80 9 915 925 2-s2.0-80054728443 10.1038/ki.2011.217
13. Kim M.-G., Su Boo C., Sook Ko Y., Young Lee H., Yong Cho W., Kyu Kim H., Jo S.-K., Depletion of kidney CD11c+ F4/80+ cells impairs the recovery process in ischaemia/reperfusion-induced acute kidney injury. Nephrology Dialysis Transplantation 2010 25 9 2908 2921 2-s2.0-77956254268 10.1093/ndt/gfq183
14. Lee S., Huen S., Nishio H., Nishio S., Lee H. K., Choi B.-S., Ruhrberg C., Cantley L. G., Distinct macrophage phenotypes contribute to kidney injury and repair. Journal of the American Society of Nephrology 2011 22 2 317 326 2-s2.0-79551654684 10.1681/ASN.2009060615
15. Zhang M. Z., Yao B., Yang S., CSF-1 signaling mediates recovery from acute kidney injury. The Journal of Clinical Investigation 2012 122 12 4519 4532
16. Lech M., Gröbmayr R., Ryu M., Macrophage phenotype controls longterm AKI outcomes-kidney regeneration versus atrophy. Journal of the American Society of Nephrology. In press
17. Dehmel S., Wang S., Schmidt C., Kiss E., Loewe R. P., Chilla S., Schlöndorff D., Gröne H.-J., Luckow B., Chemokine receptor Ccr5 deficiency induces alternative macrophage activation and improves long-term renal allograft outcome. European Journal of Immunology 2010 40 1 267 278 2-s2.0-74249121961 10.1002/eji.200939652
18. Duffield J. S., Forbes S. J., Constandinou C. M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., Iredale J. P., Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. The Journal of Clinical Investigation 2005 115 1 56 65 2-s2.0-13744255589 10.1172/JCI200522675 (Pubitemid 40385505)
19. Tamura T., Yanai H., Savitsky D., Taniguchi T., The IRF family transcription factors in immunity and oncogenesis. Annual Review of Immunology 2008 26 535 584 2-s2.0-42649114059 10.1146/annurev.immunol.26.021607.090400 (Pubitemid 351600385)
20. Escalante C. R., Yie J., Thanos D., Aggarwal A. K., Structure of IRF-1 with bound DNA reveals determinants of interferon regulation. Nature 1998 391 6662 103 106 2-s2.0-0031933646 10.1038/34224 (Pubitemid 28079225)
21. Lohoff M., Mak T. W., Roles of interferon-regulatory factors in T-helper-cell differentiation. Nature Reviews Immunology 2005 5 2 125 135 2-s2.0-13444283466 10.1038/nri1552 (Pubitemid 40208902)
22. Takaoka A., Tamura T., Taniguchi T., Interferon regulatory factor family of transcription factors and regulation of oncogenesis. Cancer Science 2008 29 3 467 478 2-s2.0-38949212626 10.1111/j.1349-7006.2007.00720.x (Pubitemid 351228562)
23. Matsuyama T., Kimura T., Kitagawa M., Pfeffer K., Kawakami T., Watanabe N., Kundig T. M., Amakawa R., Kishihara K., Wakeham A., Potter J., Furlonger C. L., Narendran A., Suzuki H., Ohashi P. S., Paige C. J., Taniguchi T., Mak T. W., Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development. Cell 1993 75 1 83 97 2-s2.0-0027361463 10.1016/0092-8674(93)90681-F (Pubitemid 23306023)
24. Miyamoto M., Fujita T., Kimura Y., Maruyama M., Harada H., Sudo Y., Miyata T., Taniguchi T., Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN- β gene regulatory elements. Cell 1988 54 6 903 913 2-s2.0-0023788435
25. Fujita T., Kimura Y., Miyamoto M., Barsoumian E. L., Taniguchi T., Induction of endogenous IFN- α and IFN- β genes by a regulatory transcription factor, IRF-1. Nature 1989 337 6204 270 272 2-s2.0-0024546241 (Pubitemid 19030564)
26. Martinez F. O., Gordon S., Locati M., Mantovani A., Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. Journal of Immunology 2006 177 10 7303 7311 2-s2.0-33750813483 (Pubitemid 44715100)
27. Negishi H., Fujita Y., Yanai H., Sakaguchi S., Ouyang X., Shinohara M., Takayanagi H., Ohba Y., Taniguchi T., Honda K., Evidence for licensing of IFN- γ -induced IFN regulatory factor 1 transcription factor by MyD88 in Toll-like receptor-dependent gene induction program. Proceedings of the National Academy of Sciences of the United States of America 2006 103 41 15136 15141 2-s2.0-33750064259 10.1073/pnas.0607181103 (Pubitemid 44583177)
28. Liu J., Cao S., Herman L. M., Ma X., Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma-primed IL-12 production by IFN regulatory factor 1. The Journal of Experimental Medicine 2003 198 8 1265 1276 2-s2.0-0142156744 10.1084/jem.20030026 (Pubitemid 37323391)
29. Lin R., Hiscott J., A role for casein kinase II phosphorylation in the regulation of IRF-1 transcriptional activity. Molecular and Cellular Biochemistry 1999 191 1-2 169 180 2-s2.0-0033000436 (Pubitemid 29092724)
30. Carey M., The enhanceosome and transcriptional synergy. Cell 1998 92 1 5 8 2-s2.0-0032498230 10.1016/S0092-8674(00)80893-4 (Pubitemid 28053292)
31. Blanco J. C. G., Contursi C., Salkowski C. A., DeWitt D. L., Ozato K., Vogel S. N., Interferon regulatory factor (IRF)-1 and IRF-2 regulate interferon γ-dependent cyclooxygenase 2 expression. The Journal of Experimental Medicine 2000 191 12 2131 2144 2-s2.0-0034686471 10.1084/jem.191.12.2131 (Pubitemid 30416360)
32. Sanceau J., Kaisho T., Hirano T., Wietzerbin J., Triggering of the human interleukin-6 gene by interferon- γ and tumor necrosis factor- α in monocytic cells involves cooperation between interferon regulatory factor-1, NF B, and Sp1 transcription factors. The Journal of Biological Chemistry 1995 270 46 27920 27931 2-s2.0-0028865771 10.1074/jbc.270.46.27920
33. Nakagawa K., Yokosawa H., PIAS3 induces SUMO-1 modification and transcriptional repression of IRF-1. FEBS Letters 2002 530 1-3 204 208 2-s2.0-0037163859 10.1016/S0014-5793(02)03486-5 (Pubitemid 35248212)
34. Nhu M. Q., Cuesta N., Vogel S. N., Transcriptional regulation of lipopolysaccharide (LPS)-induced Toll-like receptor (TLR) expression in murine macrophages: role of interferon regulatory factors 1 (IRF-1) and 2 (IRF-2). Journal of Endotoxin Research 2006 12 5 285 295 2-s2.0-34249004485 10.1177/09680519060120050401 (Pubitemid 47471340)
35. Kamijo R., Harada H., Matsuyama T., Bosland M., Gerecitano J., Shapiro D., Le J., Koh S. I., Kimura T., Green S. J., Mak T. W., Taniguchi T., Vilček J., Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 1994 263 5153 1612 1615 2-s2.0-0028348307 (Pubitemid 24128365)
36. Taki S., Sato T., Ogasawara K., Fukuda T., Sato M., Hida S., Suzuki G., Mitsuyama M., Shin E.-H., Kojima S., Taniguchi T., Asano Y., Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 1997 6 6 673 679 2-s2.0-0030741433 10.1016/S1074-7613(00)80443-4 (Pubitemid 27305730)
37. Elser B., Lohoff M., Kock S., Giaisi M., Kirchhoff S., Krammer P. H., Li-Weber M., IFN- γ represses IL-4 expression via IRF-1 and IRF-2. Immunity 2002 17 6 703 712 2-s2.0-18744386097 10.1016/S1074-7613(02)00471-5 (Pubitemid 35477790)
38. Khan I. A., Matsuura T., Fonseka S., Kasper L. H., Production of nitric oxide (NO) is not essential for protection against acute Toxoplasma gondii infection in IRF-1-/- Mice. Journal of Immunology 1996 156 2 636 643 2-s2.0-0030060390
39. Iadecola C., Salkowski C. A., Zhang F., Aber T., Nagayama M., Vogel S. N., Ross M. E., The transcription factor interferon regulatory factor 1 is expressed after cerebral ischemia and contributes to ischemic brain injury. The Journal of Experimental Medicine 1999 189 4 719 727 2-s2.0-0033557359 10.1084/jem.189.4.719 (Pubitemid 29193373)
40. Wang Y., John R., Chen J., Richardson J. A., Shelton J. M., Bennett M., Zhou X. J., Nagami G. T., Zhang Y., Qing Q. W., Lu C. Y., IRF-1 promotes inflammation early after ischemic acute kidney injury. Journal of the American Society of Nephrology 2009 20 7 1544 1555 2-s2.0-67649703123 10.1681/ASN.2008080843
41. Harada H., Fujita T., Miyamoto M., Kimura Y., Maruyama M., Furia A., Miyata T., Taniguchi T., Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes. Cell 1989 58 4 729 739 2-s2.0-0024380583 (Pubitemid 19210966)
42. Cuesta N., Salkowski C. A., Thomas K. E., Vogel S. N., Regulation of lipopolysaccharide sensitivity by IFN regulatory factor-21. Journal of Immunology 2003 170 11 5739 5747 2-s2.0-0038527326 (Pubitemid 36617867)
43. Han K.-J., Jiang L., Shu H.-B., Regulation of IRF2 transcriptional activity by its sumoylation. Biochemical and Biophysical Research Communications 2008 372 4 772 778 2-s2.0-46149092730 10.1016/j.bbrc.2008.05.103
44. Cuesta N., Nhu Q. M., Zudaire E., Polumuri S., Cuttitta F., Vogel S. N., IFN regulatory factor-2 regulates macrophage apoptosis through a STAT1/3- and caspase-1-dependent mechanism. Journal of Immunology 2007 178 6 3602 3611 2-s2.0-33947278297 (Pubitemid 46417627)
45. Fehr T., Schoedon G., Odermatt B., Holtschke T., Schneemann M., Bachmann M. F., Mak T. W., Horak I., Zinkernagel R. M., Crucial role of interferon consensus sequence binding protein, but neither of interferon regulatory factor 1 nor of nitric oxide synthesis for protection against murine listeriosis. The Journal of Experimental Medicine 1997 185 5 921 931 2-s2.0-0030896666 10.1084/jem.185.5.921 (Pubitemid 27119876)
46. Salkowski C. A., Barber S. A., Detore G. R., Vogel S. N., Differential dysregulation of nitric oxide production in macrophages with targeted disruptions in IFN regulatory factor-1 and -2 genes. Journal of Immunology 1996 156 9 3107 3110 2-s2.0-0029901302 (Pubitemid 26123522)
47. Klune J. R., Dhupar R., Kimura S., Interferon regulatory factor-2 is protective against hepatic ischemia-reperfusion injury. American Journal of Physiology. Gastrointestinal and Liver Physiology 2012 303 5 G666 G673
48. Hida S., Ogasawara K., Sato K., Abe M., Takayanagi H., Yokochi T., Sato T., Hirose S., Shirai T., Taki S., Taniguchi T., CD8+ T cell-mediated skin disease in mice lacking IRF-2, the transcriptional attenuator of interferon- α / β signaling. Immunity 2000 13 5 643 655 2-s2.0-0033635304
49. Ichikawa E., Hida S., Omatsu Y., Shimoyama S., Takahara K., Miyagawa S., Inaba K., Taki S., Defective development of splenic and epidermal CD4+ dendritic cells in mice deficient for IFN regulatory factor-2. Proceedings of the National Academy of Sciences of the United States of America 2004 101 11 3909 3914 2-s2.0-1642295557 10.1073/pnas.0400610101 (Pubitemid 38381076)
50. Au W.-C., Moore P. A., Lowther W., Juang Y.-T., Pitha P. M., Identification of a member of the interferon regulatory factor family that binds to the interferon-stimulated response element and activates expression of interferon-induced genes. Proceedings of the National Academy of Sciences of the United States of America 1995 92 25 11657 11661 2-s2.0-0029618697 10.1073/pnas.92.25.11657 (Pubitemid 26014172)
51. Nguyen H., Hiscott J., Pitha P. M., The growing family of interferon regulatory factors. Cytokine and Growth Factor Reviews 1997 8 4 293 312 2-s2.0-0031418944 10.1016/S1359-6101(97)00019-1 (Pubitemid 28201655)
52. Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., Takeuchi O., Sugiyama M., Okabe M., Takeda K., Akira S., Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science 2003 301 5633 640 643 2-s2.0-0043176281 10.1126/science.1087262 (Pubitemid 36927946)
53. Fitzgerald K. A., Rowe D. C., Barnes B. J., Caffrey D. R., Visintin A., Latz E., Monks B., Pitha P. M., Golenbock D. T., LPS-TLR4 signaling to IRF-3/7 and NF- B involves the toll adapters TRAM and TRIF. The Journal of Experimental Medicine 2003 198 7 1043 1055 2-s2.0-0141959224 10.1084/jem.20031023 (Pubitemid 37248620)
54. Honda K., Taniguchi T., IRFs: master regulators of signalling by Toll-like receptors and cytosolic pattern-recognition receptors. Nature Reviews Immunology 2006 6 9 644 658 2-s2.0-33748051738 10.1038/nri1900 (Pubitemid 44298214)
55. Akira S., Uematsu S., Takeuchi O., Pathogen recognition and innate immunity. Cell 2006 124 4 783 801 2-s2.0-32944464648 10.1016/j.cell.2006.02.015 (Pubitemid 43261452)
56. Ishikawa H., Ma Z., Barber G. N., STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 2009 461 7265 788 792 2-s2.0-70349943834 10.1038/nature08476
57. Panne D., Maniatis T., Harrison S. C., An atomic model of the interferon-beta enhanceosome. Cell 2007 129 6 1111 1123 2-s2.0-34250017968 10.1016/j.cell.2007.05.019 (Pubitemid 46891042)
58. Takahasi K., Suzuki N. N., Horiuchi M., Mori M., Suhara W., Okabe Y., Fukuhara Y., Terasawa H., Akira S., Fujita T., Inagaki F., X-ray crystal structure of IRF-3 and its functional implications. Nature Structural Biology 2003 10 11 922 927 2-s2.0-0242658895 10.1038/nsb1001 (Pubitemid 37386101)
59. Panne D., McWhirter S. M., Maniatis T., Harrison S. C., Interferon regulatory factor 3 is regulated by a dual phosphorylation- dependent switch. The Journal of Biological Chemistry 2007 282 31 22816 22822 2-s2.0-34547930163 10.1074/jbc.M703019200 (Pubitemid 47267373)
60. Qin B. Y., Liu C., Srinath H., Lam S. S., Correia J. J., Derynck R., Lin K., Crystal structure of IRF-3 in complex with CBP. Structure 2005 13 9 1269 1277 2-s2.0-24344487414 10.1016/j.str.2005.06.011 (Pubitemid 41262094)
61. Zhang M., Tian Y., Wang R.-P., Gao D., Zhang Y., Diao F.-C., Chen D.-Y., Zhai Z.-H., Shu H.-B., Negative feedback regulation of cellular antiviral signaling by RBCK1-mediated degradation of IRF3. Cell Research 2008 18 11 1096 1104 2-s2.0-55549146091 10.1038/cr.2008.277
62. Fleetwood A. J., Dinh H., Cook A. D., Hertzog P. J., Hamilton J. A., GM-CSF- and M-CSF-dependent macrophage phenotypes display differential dependence on Type I interferon signaling. Journal of Leukocyte Biology 2009 86 2 411 421 2-s2.0-69449085100 10.1189/jlb.1108702
63. Biswas S. K., Gangi L., Paul S., Schioppa T., Saccani A., Sironi M., Bottazzi B., Doni A., Vincenzo B., Pasqualini F., Vago L., Nebuloni M., Mantovani A., Sica A., A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF- B and enhanced IRF-3/STAT1 activation). Blood 2006 107 5 2112 2122 2-s2.0-33344460032 10.1182/blood-2005- 01-0428 (Pubitemid 43289397)
64. Tarassishin L., Suh H.-S., Lee S. C., Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway. Journal of Neuroinflammation 2011 8, article 187 2-s2.0-84855172549 10.1186/1742-2094-8-187
65. Lin R., Heylbroeck C., Genin P., Pitha P. M., Hiscott J., Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Molecular and Cellular Biology 1999 19 2 959 966 2-s2.0-0032926882 (Pubitemid 29046840)
66. Eisenbeis C. F., Singh H., Storb U., Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes and Development 1995 9 11 1377 1387 2-s2.0-0029073345
67. Mittrücker H.-W., Matsuyama T., Grossman A., Kündig T. M., Potter J., Shahinian A., Wakeham A., Patterson B., Ohashi P. S., Mak T. W., Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997 275 5299 540 543 2-s2.0-15444346834 10.1126/science.275.5299.540 (Pubitemid 27051911)
68. Lawrence T., Natoli G., Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nature Reviews Immunology 2011 11 11 750 761 2-s2.0-80355146399 10.1038/nri3088
69. Ahyi A.-N. N., Chang H.-C., Dent A. L., Nutt S. L., Kaplan M. H., IFN regulatory factor 4 regulates the expression of a subset of Th2 cytokines. Journal of Immunology 2009 183 3 1598 1606 2-s2.0-68149125188 10.4049/jimmunol.0803302
70. Honma K., Udono H., Kohno T., Yamamoto K., Ogawa A., Takemori T., Kumatori A., Suzuki S., Matsuyama T., Yui K., Interferon regulatory factor 4 negatively regulates the production of proinflammatory cytokines by macropages in response to LPS. Proceedings of the National Academy of Sciences of the United States of America 2005 102 44 16001 16006 2-s2.0-27644553011 10.1073/pnas.0504226102 (Pubitemid 41552857)
71. El Chartouni C., Schwarzfischer L., Rehli M., Interleukin-4 induced interferon regulatory factor (Irf) 4 participates in the regulation of alternative macrophage priming. Immunobiology 2010 215 9-10 821 825 2-s2.0-77955426821 10.1016/j.imbio.2010.05.031
72. Satoh T., Takeuchi O., Vandenbon A., Yasuda K., Tanaka Y., Kumagai Y., Miyake T., Matsushita K., Okazaki T., Saitoh T., Honma K., Matsuyama T., Yui K., Tsujimura T., Standley D. M., Nakanishi K., Nakai K., Akira S., The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nature Immunology 2010 11 10 936 944 2-s2.0-77956954197 10.1038/ni.1920
73. Ishii M., Wen H., Corsa C. A. S., Liu T., Coelho A. L., Allen R. M., Carson W. F. IV, Cavassani K. A., Li X., Lukacs N. W., Hogaboam C. M., Dou Y., Kunkel S. L., Epigenetic regulation of the alternatively activated macrophage phenotype. Blood 2009 114 15 3244 3254 2-s2.0-70350435962 10.1182/blood-2009-04- 217620
74. Takaoka A., Yanai H., Kondo S., Duncan G., Negishi H., Mizutani T., Kano S.-I., Honda K., Ohba Y., Mak T. W., Taniguchi T., Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature 2005 434 7030 243 249 2-s2.0-15044345461 10.1038/nature03308 (Pubitemid 40388058)
75. Paun A., Bankoti R., Joshi T., Pitha P. M., Stäger S., Critical role of IRF-5 in the development of t helper 1 responses to Leishmania donovani infection. PLoS Pathogens 2011 7 1 2-s2.0-79551508963 10.1371/journal.ppat. 1001246 e1001246
76. Savitsky D. A., Yanai H., Tamura T., Taniguchi T., Honda K., Contribution of IRF5 in B cells to the development of murine SLE-like disease through its transcriptional control of the IgG2a locus. Proceedings of the National Academy of Sciences of the United States of America 2010 107 22 10154 10159 2-s2.0-77953368347 10.1073/pnas.1005599107
77. Lacey D. C., Achuthan A., Fleetwood A. J., Dinh H., Roiniotis J., Scholz G. M., Chang M. W., Beckman S. K., Cook A. D., Hamilton J. A., Defining GM-CSF- and macrophage-CSF-dependent macrophage responses by in vitro models. Journal of Immunology 2012 188 11 5752 5765
78. Eames H. L., Saliba D. G., Krausgruber T., Lanfrancotti A., Ryzhakov G., Udalova I. A., KAP1/TRIM28: an inhibitor of IRF5 function in inflammatory macrophages. Immunobiology 2012 217 12 1315 1324
79. Krausgruber T., Blazek K., Smallie T., Alzabin S., Lockstone H., Sahgal N., Hussell T., Feldmann M., Udalova I. A., IRF5 promotes inflammatory macrophage polarization and TH1-TH17 responses. Nature Immunology 2011 12 3 231 238 2-s2.0-79951671510 10.1038/ni.1990
80. Hedl M., Abraham C., IRF5 risk polymorphisms contribute to interindividual variance in pattern recognition receptor-mediated cytokine secretion in human monocyte-derived cells. Journal of Immunology 2012 188 11 5348 5356
81. Feng D., Stone R. C., Eloranta M.-L., Sangster-Guity N., Nordmark G., Sigurdsson S., Wang C., Alm G., Syvänen A.-C., Rönnblom L., Barnes B. J., Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus. Arthritis and Rheumatism 2010 62 2 562 573 2-s2.0-75749153301 10.1002/art.27223
82. Graham R. R., Kyogoku C., Sigurdsson S., Vlasova I. A., Davies L. R. L., Baechler E. C., Plenge R. M., Koeuth T., Ortmann W. A., Hom G., Bauer J. W., Gillett C., Burtt N., Graham D. S. C., Onofrio R., Petri M., Gunnarsson I., Svenungsson E., Rönnblom L., Nordmark G., Gregersen P. K., Moser K., Gaffney P. M., Criswell L. A., Vyse T. J., Syvänen A.-C., Bohjanen P. R., Daly M. J., Behrens T. W., Altshuler D., Three functional variants of IFN regulatory factor 5 (IRF5) define risk and protective haplotypes for human lupus. Proceedings of the National Academy of Sciences of the United States of America 2007 104 16 6758 6763 2-s2.0-34249860408 10.1073/pnas.0701266104 (Pubitemid 47175574)
83. Stone R. C., Feng D., Deng J., Singh S., Yang L., Fitzgerald-Bocarsly P., Eloranta M.-L., Rönnblom L., Barnes B. J., Interferon regulatory factor 5 activation in monocytes of systemic lupus erythematosus patients is triggered by circulating autoantigens independent of type I interferons. Arthritis and Rheumatism 2012 64 3 788 798 2-s2.0-84857780003 10.1002/art.33395
84. Zucchero T. M., Cooper M. E., Maher B. S., Daack-Hirsch S., Nepomuceno B., Ribeiro L., Caprau D., Christensen K., Suzuki Y., Machida J., Natsume N., Yoshiura K.-I., Vieira A. R., Orioli I. M., Castilla E. E., Moreno L., Arcos-Burgos M., Lidral A. C., Field L. L., Liu Y.-E., Ray A., Goldstein T. H., Schultz R. E., Shi M., Johnson M. K., Kondo S., Schutte B. C., Marazita M. L., Murray J. C., Interferon regulatory factor 6 (IRF6) gene variants and the risk of isolated cleft lip or palate. The New England Journal of Medicine 2004 351 8 769 780 2-s2.0-4143115809 10.1056/NEJMoa032909 (Pubitemid 39095312)
85. Ingraham C. R., Kinoshita A., Kondo S., Yang B., Sajan S., Trout K. J., Malik M. I., Dunnwald M., Goudy S. L., Lovett M., Murray J. C., Schutte B. C., Abnormal skin, limb and craniofacial morphogenesis in mice deficient for interferon regulatory factor 6 (Irf6). Nature Genetics 2006 38 11 1335 1340 2-s2.0-33750452339 10.1038/ng1903 (Pubitemid 44646298)
86. Sato M., Suemori H., Hata N., Asagiri M., Ogasawara K., Nakao K., Nakaya T., Katsuki M., Noguchi S., Tanaka N., Taniguchi T., Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN- α / β gene induction. Immunity 2000 13 4 539 548 2-s2.0-0033680737
87. Sato M., Hata N., Asagiri M., Nakaya T., Taniguchi T., Tanaka N., Positive feedback regulation of type I IFN genes by the IFN-inducible transcription factor IRF-7. FEBS Letters 1998 441 1 106 110 2-s2.0-0032434924 10.1016/S0014-5793(98)01514-2 (Pubitemid 29012382)
88. Qi C.-F., Li Z., Raffeld M., Wang H., Kovalchuk A. L., Morse H. C. III, Differential expression of IRF8 in subsets of macrophages and dendritic cells and effects of IRF8 deficiency on splenic B cell and macrophage compartments. Immunologic Research 2009 45 1 62 74 2-s2.0-70349748738 10.1007/s12026-008-8032- 2
89. Wang H., Morse H. C. III, IRF8 regulates myeloid and B lymphoid lineage diversification. Immunologic Research 2009 43 1-3 109 117 2-s2.0-66549125977 10.1007/s12026-008-8055-8
90. Becker A. M., Michael D. G., Satpathy A. T., Sciammas R., Singh H., Bhattacharya D., IRF-8 extinguishes neutrophil production and promotes dendritic cell lineage commitment in both myeloid and lymphoid mouse progenitors. Blood 2012 119 9 2003 2012 2-s2.0-84857724877 10.1182/blood-2011-06-364976
91. Laricchia-Robbio L., Tamura T., Karpova T., Sprague B. L., McNally J. G., Ozato K., Partner-regulated interaction of IFN regulatory factor 8 with chromatin visualized in live macrophages. Proceedings of the National Academy of Sciences of the United States of America 2005 102 40 14368 14373 2-s2.0-26444490607 10.1073/pnas.0504014102 (Pubitemid 41429704)
92. Holtschke T., Löhler J., Kanno Y., Fehr T., Giese N., Rosenbauer F., Lou J., Knobeloch K.-P., Gabriele L., Waring J. F., Bachmann M. F., Zinkernagel R. M., Morse H. C. III, Ozato K., Horak I., Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 1996 87 2 307 317 2-s2.0-16044369709 10.1016/S0092-8674(00)81348-3 (Pubitemid 26359008)
93. Xu H., Zhu J., Smith S., Notch-RBP-J signaling regulates the transcription factor IRF8 to promote inflammatory macrophage polarization. Nature Immunology 2012 13 7 642 650
94. Chang T. H., Xu S., Tailor P., Kanno T., Ozato K., The small ubiquitin-like modifier-deconjugating enzyme sentrin-specific peptidase 1 switches IFN regulatory factor 8 from a repressor to an activator during macrophage activation. Journal of Immunology 2012 189 7 3548 3556
95. Reich N. C., Liu L., Tracking STAT nuclear traffic. Nature Reviews Immunology 2006 6 8 602 612 2-s2.0-33746570647 10.1038/nri1885 (Pubitemid 44134093)